With the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks ...

For instance, studies have shown that approximately 25% of adults with diabetes reported rationing insulin in the previous ...

Cambridge, Massachusetts-based Vor Bio has confirmed that it will halt clinical and manufacturing operations, including its ...

The GLISTEN trial of GSK's linerixibat has shown that the oral ileal bile acid transporter (IBAT inhibitor was signposted as ...

Moreover, Downing Street has indicated that the UK will receive "preferential treatment in any further tariffs imposed" as ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC).

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic ...

Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated ...

Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in ...

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...